National Biotechnology Initiative Act of 2025

National Biotechnology Initiative Act of 2025 This bill establishes an interagency biotechnology initiative to coordinate and advance federal biotechnology activities, including research, product regulation, and national security efforts. The bill implements several recommendations issued by the National Security Commission on Emerging Biotechnology in its April 2025 final report . Under the bill, agencies participating in the initiative must conduct or support biotechnology-related activities in coordination with the initiative, such as (1) supporting the development and commercialization of biotechnology products, (2) coordinating with industry on threat information sharing and risk mitigation, and (3) supporting the development of a domestic biotechnology workforce. Further, the bill provides for an executive office and interagency committee to coordinate and support initiative activities. Among other functions, the office must assess and address national security, economic security, and biosafety issues associated with emerging biotechnology; coordinate support for biotechnology research and development, including by supporting a national network of biotechnology testbeds; negotiate interagency agreements to establish clear regulatory pathways for biotechnology products; and develop an outreach strategy to improve international market access for U.S. biotechnology products. The office and committee must jointly publish a website with information about federal biotechnology activities and must periodically publish and submit to Congress a comprehensive national strategy for biotechnology. The Government Accountability Office must periodically review and report to Congress on the activities of the office and committee. The office must wind down and transition most of its functions to the committee after 20 years.